Cravath, Swaine & Moore LLP Logo
  • Practices
  • People
  • Careers
  • News & Insights
  • Practices
  • People
  • Careers
  • News & Insights
  • Our Story
  • The Cravath System
  • Diversity & Inclusion
  • Pro Bono
  • Alumni Journal
  • 200.Cravath

Cravath Publishes Winter 2026 Issue of Alumni Journal

Read More

Industries

Industrials and Chemicals

Industrials and Chemicals

From representing Charles Goodyear in the 1850s to advising Linde in its merger with Praxair, Cravath has maintained its position representing clients at the forefront of the industrials sector. The Firm also has extensive experience representing companies in virtually all areas of the chemicals industry, including the manufacture, distribution and sale of specialty, diversified and commodity chemicals.

Cravath’s corporate lawyers have represented industrials and chemicals clients in mergers and acquisitions, bank financings, securities offerings, financial restructurings and reorganizations and corporate board advisory matters, including ESG reporting requirements and governance processes. Our litigators are trusted advisors that routinely work with these clients on antitrust, intellectual property, general commercial, unfair competition, securities, class action, arbitration and other litigation matters.

Cravath’s corporate lawyers have represented industrials and chemicals clients in mergers and acquisitions, bank financings, securities offerings, financial restructurings and reorganizations and corporate board advisory matters, including ESG reporting requirements and governance processes. Our litigators are trusted advisors that routinely work with these clients on antitrust, intellectual property, general commercial, unfair competition, securities, class action, arbitration and other litigation matters.

  • Deals & Cases
  • Recent News & Insights

Deals & Cases

February 20, 2026

First Solar’s $1.5 Billion Revolving Credit Facility

Cravath represented First Solar, Inc. in connection with its $1.5 billion revolving credit facility. First Solar is America’s leading photovoltaic solar technology and manufacturing company, and the only US‑headquartered company among the world’s largest solar manufacturers. The transaction closed on February 13, 2026.

Deals & Cases

February 18, 2026

Tenax’s Merger with Air

On February 17, 2026, Tenax Aerospace Acquisition, LLC (“Tenax”) and Air Industries Group (“Air”) jointly announced that they have entered into an Agreement and Plan of Merger to combine Tenax’s special mission aviation business with Air’s precision aerospace manufacturing business. At the time of the merger, Air will issue shares of its common stock to holders of Tenax membership units. After the closing, Tenax shareholders are expected to own approximately 95% of Air’s outstanding shares while existing Air shareholders are expected to own approximately 5%, and the combined company expects to remain listed on the NYSE American under the symbol AIRI. Cravath is representing Tenax in connection with the transaction.

Deals & Cases

January 29, 2026

AerCap Ireland Capital Designated Activity Company and AerCap Global Aviation Trust’s $1.75 Billion Registered Senior Notes Offering

Cravath represented AerCap Ireland Capital Designated Activity Company and AerCap Global Aviation Trust in connection with their $1.75 billion registered senior notes offering. AerCap Ireland Capital Designated Activity Company and AerCap Global Aviation Trust are wholly owned subsidiaries of AerCap Holdings N.V., the global leader in aircraft leasing. The notes were listed on the Irish Stock Exchange. The transaction closed on January 15, 2026.

Deals & Cases

January 27, 2026

Siegfried’s Acquisition of Noramco, Purisys and Extractas

On January 27, 2026, Siegfried, a leading global Contract Development and Manufacturing Organization for the pharmaceutical industry, announced it has signed binding agreements with an affiliate of SK Capital Partners to acquire the drug substance business of the Noramco Group and Extractas Bioscience (“Extractas”). The acquired businesses include Noramco, Purisys and Extractas, three high-quality small molecules drug substances sites. Cravath is representing Siegfried in connection with the transaction.

Deals & Cases

January 07, 2026

Mattamy Group Corporation’s High‑Yield Senior Notes Offerings

Cravath represented the initial purchasers in connection with the $475 million and C$350 million 144A/Reg. S high‑yield senior notes offering of Mattamy Group Corporation, North America's largest privately owned homebuilder and Canada’s largest new home construction and development firm at the time of the offering. The transactions closed on December 17, 2025.

Activities

December 10, 2025

Financial Times Recognizes Cravath in Dealmaking Category of 2025 North America Innovative Lawyers Report

On December 9, 2025, Cravath was recognized by the Financial Times in connection with its annual “North America Innovative Lawyers” report, which showcases “the most innovative work and legal services that lawyers have developed for clients in North America.” The Firm received “Highly commended” honors in the “Dealmaking” category for its representation of Vista Outdoor in its $1.125 billion sale of Revelyst to SVP and $2.225 billion sale of The Kinetic Group to CSG.

Activities

December 03, 2025

Cravath’s Antitrust Practice Ranks as “Elite” in GCR 100

On November 28, 2025, Cravath’s antitrust practice was ranked among the “Elite” in Global Competition Review’s 2026 edition of GCR 100, a guide to the world’s best competition practices. This is the fourteenth consecutive year the Firm has been ranked in the highest tier among New York Firms by GCR. The publication highlighted Cravath as a “premier choice for major antitrust litigation, enforcement actions and high‑profile transactional matters,” noting its representations of clients including Corteva in antitrust litigation brought by the FTC and related putative class actions; Elsevier in putative class action antitrust litigation; Epic Systems in an action filed by Particle Health; and Wiz on antitrust matters in connection with its $32 billion acquisition by Google.

Activities

October 23, 2025

IFLR Recognizes “Sharp Ascent” by Cravath in 2025 Western Europe Rankings

In an article highlighting the October release of the 2025 edition of IFLR1000, IFLR named Cravath among the law firms that “made the largest strides in the banking and finance rankings across four key European markets this year.” It further pointed to Cravath’s “sharp ascent” in rankings as evidence of U.S. firms becoming increasingly active in London’s finance space. The 2025 edition of IFLR1000 recognized Cravath across five categories: Bank Lending – Lender Side, Bank Lending – Sponsor Side, Capital Markets – Debt, Capital Markets – Equity and Capital Markets – High Yield.

Activities

September 19, 2025

Financial Times Recognizes Cravath with “Innovative Lawyers in Dealmaking” Award at Innovative Lawyer Europe Awards 2025

On September 18, 2025, the Financial Times recognized Cravath at the publication’s Innovative Lawyer Europe Awards 2025, which recognize the most innovative work and legal service lawyers have developed for their clients in Europe. Cravath was chosen as the winner in the “Dealmaking” category in recognition of the Firm’s representation of the lead arrangers and initial purchasers in the €1.9 billion financing supporting TDR Capital and I Squared Capital’s public-to-private acquisition of Applus+.

Publications

August 11, 2025

Cravath Publishes Quarterly Review on Q2 2025 Trends in M&A, Activism and Corporate Governance

On August 11, 2025, Cravath published the latest edition of its Quarterly Review, which provides insight into practical points, key takeaways and relevant developments across the M&A, activism, tax, regulatory and corporate governance landscape. This edition covers:

Deals & Cases

February 20, 2026

First Solar’s $1.5 Billion Revolving Credit Facility

Cravath represented First Solar, Inc. in connection with its $1.5 billion revolving credit facility. First Solar is America’s leading photovoltaic solar technology and manufacturing company, and the only US‑headquartered company among the world’s largest solar manufacturers. The transaction closed on February 13, 2026.

Deals & Cases

February 18, 2026

Tenax’s Merger with Air

On February 17, 2026, Tenax Aerospace Acquisition, LLC (“Tenax”) and Air Industries Group (“Air”) jointly announced that they have entered into an Agreement and Plan of Merger to combine Tenax’s special mission aviation business with Air’s precision aerospace manufacturing business. At the time of the merger, Air will issue shares of its common stock to holders of Tenax membership units. After the closing, Tenax shareholders are expected to own approximately 95% of Air’s outstanding shares while existing Air shareholders are expected to own approximately 5%, and the combined company expects to remain listed on the NYSE American under the symbol AIRI. Cravath is representing Tenax in connection with the transaction.

Deals & Cases

January 29, 2026

AerCap Ireland Capital Designated Activity Company and AerCap Global Aviation Trust’s $1.75 Billion Registered Senior Notes Offering

Cravath represented AerCap Ireland Capital Designated Activity Company and AerCap Global Aviation Trust in connection with their $1.75 billion registered senior notes offering. AerCap Ireland Capital Designated Activity Company and AerCap Global Aviation Trust are wholly owned subsidiaries of AerCap Holdings N.V., the global leader in aircraft leasing. The notes were listed on the Irish Stock Exchange. The transaction closed on January 15, 2026.

Deals & Cases

January 27, 2026

Siegfried’s Acquisition of Noramco, Purisys and Extractas

On January 27, 2026, Siegfried, a leading global Contract Development and Manufacturing Organization for the pharmaceutical industry, announced it has signed binding agreements with an affiliate of SK Capital Partners to acquire the drug substance business of the Noramco Group and Extractas Bioscience (“Extractas”). The acquired businesses include Noramco, Purisys and Extractas, three high-quality small molecules drug substances sites. Cravath is representing Siegfried in connection with the transaction.

Deals & Cases

January 07, 2026

Mattamy Group Corporation’s High‑Yield Senior Notes Offerings

Cravath represented the initial purchasers in connection with the $475 million and C$350 million 144A/Reg. S high‑yield senior notes offering of Mattamy Group Corporation, North America's largest privately owned homebuilder and Canada’s largest new home construction and development firm at the time of the offering. The transactions closed on December 17, 2025.

Activities

December 10, 2025

Financial Times Recognizes Cravath in Dealmaking Category of 2025 North America Innovative Lawyers Report

On December 9, 2025, Cravath was recognized by the Financial Times in connection with its annual “North America Innovative Lawyers” report, which showcases “the most innovative work and legal services that lawyers have developed for clients in North America.” The Firm received “Highly commended” honors in the “Dealmaking” category for its representation of Vista Outdoor in its $1.125 billion sale of Revelyst to SVP and $2.225 billion sale of The Kinetic Group to CSG.

Activities

December 03, 2025

Cravath’s Antitrust Practice Ranks as “Elite” in GCR 100

On November 28, 2025, Cravath’s antitrust practice was ranked among the “Elite” in Global Competition Review’s 2026 edition of GCR 100, a guide to the world’s best competition practices. This is the fourteenth consecutive year the Firm has been ranked in the highest tier among New York Firms by GCR. The publication highlighted Cravath as a “premier choice for major antitrust litigation, enforcement actions and high‑profile transactional matters,” noting its representations of clients including Corteva in antitrust litigation brought by the FTC and related putative class actions; Elsevier in putative class action antitrust litigation; Epic Systems in an action filed by Particle Health; and Wiz on antitrust matters in connection with its $32 billion acquisition by Google.

Activities

October 23, 2025

IFLR Recognizes “Sharp Ascent” by Cravath in 2025 Western Europe Rankings

In an article highlighting the October release of the 2025 edition of IFLR1000, IFLR named Cravath among the law firms that “made the largest strides in the banking and finance rankings across four key European markets this year.” It further pointed to Cravath’s “sharp ascent” in rankings as evidence of U.S. firms becoming increasingly active in London’s finance space. The 2025 edition of IFLR1000 recognized Cravath across five categories: Bank Lending – Lender Side, Bank Lending – Sponsor Side, Capital Markets – Debt, Capital Markets – Equity and Capital Markets – High Yield.

Activities

September 19, 2025

Financial Times Recognizes Cravath with “Innovative Lawyers in Dealmaking” Award at Innovative Lawyer Europe Awards 2025

On September 18, 2025, the Financial Times recognized Cravath at the publication’s Innovative Lawyer Europe Awards 2025, which recognize the most innovative work and legal service lawyers have developed for their clients in Europe. Cravath was chosen as the winner in the “Dealmaking” category in recognition of the Firm’s representation of the lead arrangers and initial purchasers in the €1.9 billion financing supporting TDR Capital and I Squared Capital’s public-to-private acquisition of Applus+.

Publications

August 11, 2025

Cravath Publishes Quarterly Review on Q2 2025 Trends in M&A, Activism and Corporate Governance

On August 11, 2025, Cravath published the latest edition of its Quarterly Review, which provides insight into practical points, key takeaways and relevant developments across the M&A, activism, tax, regulatory and corporate governance landscape. This edition covers:

Cravath Bicentennial

Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.

Explore

Cravath, Swaine & Moore LLP Logo
  • CONTACT US
  • OUR STORY
  • ALUMNI PORTAL
  • DISCLAIMERS & NOTICES

Attorney Advertising. ©2026 Cravath, Swaine & Moore LLP.